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Abstract 
The Gene Ontology (GO) is a formidable resource but there are several considerations about it that 
are essential to understand the data and interpret it correctly. The GO is sufficiently simple that it can 
be used without deep understanding of its structure or how it is developed, which is both a strength 
and a weakness. In this chapter, we discuss some common misinterpretations of the ontology and the 
annotations. A better understanding of the pitfalls and the biases in the GO should help users make 
the most of this very rich resource. We also review some of the misconceptions and misleading 
assumptions commonly made about GO, including the effect of data incompleteness, the importance 
of annotation qualifiers, and the transitivity or lack thereof associated with different ontology relations. 
We also discuss several biases that can confound aggregate analyses such as gene enrichment 
analyses. For each of these pitfalls and biases, we suggest remedies and best practices. 
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1. Introduction 
As we have seen in previous chapters (e.g. ref to Hastings, ref to Bauer, ref to Pesquita), by providing 
a large amount of structured information, the Gene Ontology (GO) greatly facilitates large-scale 
analyses and data mining. A very common type of analysis entails comparing sets of genes in terms 
of their functional annotations, for instance to identify functions that are enriched or depleted in 
particular subsets of genes (Chap. X) or to assess whether particular aspects of gene function might 
be associated with other aspects of genes, such as sequence divergence or regulatory networks.  
Despite conscious efforts to keep GO data as normalised as possible, it is heterogeneous in many 
respects—to a large extent simply because the body of knowledge underlying the GO is itself very 
heterogeneous. This can introduce considerable biases when the data is used in other analysis, an 
effect that is magnified in large-scale comparisons.  
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Statisticians and epidemiologists make a clear distinction between experimental data—data from a 
controlled experiment, designed such that the case and control groups are as identical as possible in 
all respects other than a factor of interest—and observational data—data readily available, but with 
the potential presence of unknown or unmeasured factors that may confound the analysis. GO 
annotations clearly falls into the second category. Therefore, testing and controlling for potential 
confounders is of paramount importance. 
Before we go through some of the key biases and known potential confounders, let us consider 
Simpson’s Paradox, which provides a stark illustration of the perils of data aggregation. 
1.1 Simpson’s Paradox: the perils of data aggregation 
Simpson’s paradox is the counterintuitive observation that a statistical analysis of aggregated data 
(combining multiple individual datasets) can lead to dramatically different conclusions from analyses 
of each dataset taken individually, i.e. that the whole appears to disagree with the parts.  Simpson's 
paradox is easiest to grasp through an example. In the classic "Berkeley gender bias case" (1), the 
University of California at Berkeley was sued for gender bias against women applicants based on the 
aggregate 1973 admission figures (44% men admitted vs. 35% women)—an observational dataset. 
The much higher male figure appeared to be damning. However, when individually looking at the men 
vs. women admission rate for each department, the rate was in fact similar for both sexes (and even 
in favour of women in most departments). The lower overall acceptance rate for women was not due 
to gender bias, but to the tendency of women to apply to more competitive departments, which have a 
lower admission rate in general. Thus, the association between gender and admission rate in the 
aggregate data could almost entirely be explained through strong association of these two variables 
with a third, confounding variable, the department. When controlling for the confounder, the 
association between the two first variables dramatically changes. This type of phenomenon is referred 
to as Simpson’s paradox. 
Because of the inherent heterogeneity of GO data, Simpson’s paradox can manifest itself in GO 
analyses. This illustrates the importance of recognizing and controlling for potential biases and 
confounders. 
1.2 The inherent incompleteness of the Gene Ontology (Open World Assumption) 
The Gene Ontology is a representation of the current state of knowledge; thus, it is very dynamic. The 
ontology itself is constantly being improved to more accurately represent biology across all 
organisms. The ontology is augmented as new discoveries are made. At the same time, the creation 
of new annotations occurs at a rapid pace, aiming to keep up with published work. Despite these 
efforts, the information contained in the GO database, that is, the ontology and the association of 
ontology terms with genes and gene products, is necessarily incomplete. Thus, absence of evidence 
of function does not imply absence of function1. This is referred to as the Open World Assumption (2, 
3). 
Associations between genes/gene products and GO terms (“annotations”) are made via various 
methods: some manual, some automated based on the presence of protein domains or because they 
belong to certain protein families (4). Annotations can also be transferred to orthologs by manual 
processes (5), or automatically (e.g. 6, 7, reviewed in 8). There are currently over 210 million 
                                                       
1 Proteins whose function are uncharacterized are annotated to the root of the ontology, which 
formally means "this protein has some molecular_function/bp/cc, but a more specific assertion cannot 
be made”. This annotation is associated with the evidence code “No biological Data available” (ND). 
The absence of annotation indicates that no curator has reviewed the literature for this gene product. 
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annotations in the GO database. Despite these massive efforts to provide the widest possible 
coverage of gene products annotated, users should not expect each gene product to be annotated.  
A further challenge is that the incompleteness in the GO is very uneven. Interestingly, the more 
comprehensively annotated parts of the GO can also pose challenges, presenting users with 
seemingly contradictory information (see section 3.2). 
The inherent incompleteness of GO creates problems in the evaluation of computational methods. For 
instance, overlooking the Open World Assumption can lead to inflated false positive rates in the 
assessment of gene function prediction tools (3). However, there are ways of coping with this 
uncertainty. For instance, it is possible to gauge the effect of incomplete annotations on conclusions 
by thinning annotations (9), or analysing successive, increasingly complete database releases (10, 
11). 
2. Gene Ontology structure 
One potential source of bias is that not all parts of the GO have the same level of details. This has a 
strong implication on measuring the similarity of GO annotations (Chap XX). For instance, sister terms 
(terms directly attached to a common parent term) can be semantically very similar or very different in 
different parts of the GO structure, which has been called the “shallow annotation problem” (e.g. 12, 
13). This problem can partly be mitigated by the use of information-theoretic measures of similarity, 
instead of merely counting the number of edges separating terms, at the expense of requiring a 
considerable number of relevant annotations from which the frequency of co-occurrence of terms can 
be estimated (more details in Chap. [cross-reference to Sebastian Bauer’s chapter]). 
2.1 Understanding relationships between ontological concepts 
The GO is structured as a graph, and one pitfall of using the GO is to ignore this structure. Recall that 
each term is linked to other terms via different relationships (x-ref to Hasting’s Ontology primer and to 
Gaudet et al’s GO primer). These relationships need to be taken into account when using GO for data 
analysis.  
Some relationships, such as “is a” and “part of”, are transitive, which means that any protein 
annotated to a specific term is also implicitly annotated to all of its parents2. An illustration of this is a 
“serine/threonine protein kinase activity”: it is a child of “protein kinase activity” with the relationship “is 
a”. The transitivity of the relation means that the association between the protein and the term 
“serine/threonine protein kinase activity” and all its parents has the same meaning: the protein 
associated with “serine/threonine protein kinase activity” has this function, and it also has the more 
general function “protein kinase.” 
On the other hand, relations such as “regulates” are non-transitive. This implies that the semantics of 
the association of a gene to a GO term is not the same for its parent: if A is part of B, and B regulates 
C, we cannot make any inferences about the relationship between C and A. The same is true for 
positive and negative regulation. To illustrate, if we follow the term “peptidase inhibitor activity” 
(GO:0030414) to its parents, one of the terms encountered is “proteolysis” via a combination of “is a”, 
“part of”, and “regulates” relations. However a “peptidase inhibitor activity” does not mediate 
proteolysis; quite the contrary (Fig. 1). Thus, any logical reasoning on the ontology should take 
transitivity into account.  
The relation “has part” is the inverse of “part of”, and connects terms in the opposite direction. 
Because of this, it generates cycles in the ontology. The relation “occurs in” connects molecular 
                                                       
2 With the exception of “NOT” annotations, for which the transitivity applies to children terms, not 
parents (see also Sect 3.2). 
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function terms to the cellular components in which they occur. Thus, taking these relationships into 
account, it is possible to deduce additional cellular component annotations from molecular function 
annotations, without requiring additional experimental or computational evidence. 
It important to know that there are three version of the GO ontology available: GO-basic, GO, and 
GO-plus3. Only the GO-basic file is completely acyclic. Therefore, applications requiring the traversal 
of the ontology graph usually assume that the graph is acyclic; hence, the GO-basic file should be 
used. The different GO ontology files are discussed in more details in Chap. XX (citation to Chap by 
Munoz-Torrez and Carbon). 
 
 
Figure 1. Example of transitive (black arrows) and non-transitive (red arrow) relationships between 
classes. A protein annotated to “peptidase inhibitor activity” term does not imply it has a role in 
“proteolysis”, since the link is broken by the non-transitive relation negatively regulates.  
2.2 Inter-ontology links and their impact on GO enrichment analyses 
The “part of” relation, when linking terms across the different aspects of the Gene Ontology 
(molecular function to biological process, or biological process to cellular component, for instance), 
triggers an annotation to the second term, using the same evidence code and the same reference, but 
“GOC” as the source of the annotation (“field 15 of the annotation file, see GO primer chapter [x-ref] 
for a description of the contents of the annotation file). For example, a DNA ligase activity annotation 
will automatically trigger an annotation to the biological process DNA ligation. The advantage of 
having these annotations inferred directly from the ontology is that it increases the annotation 
coverage by making annotations that may have been overlooked by the annotator when making the 
primary annotation. However, these inter-ontology links trigger a large number of annotations: there 
are currently 12 million annotations to 7 million proteins in the GO database. Changes in the structure 
of these links (as any change in the ontology), can potentially have a large impact on the annotation 
set. Indeed, Huntley et al. (14) reported that in November 2011, there was a decrease of ~2,500 
manually and automatically assigned annotations to the term “transcription, DNA-dependent" 
(GO:0006351) due to the removal of an inter-ontology link between this term and the Molecular 
Function term “sequence-specific DNA binding transcription factor activity” (GO:0003700). Fig. 2 
                                                       
3 http://geneontology.org/page/download-ontology 
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shows the strong and sudden variation in the number of annotations with term “ATPase activity” 
(GO:0016887). 
 
 
 
Fig 2. Strong and sudden variation in the number of annotations with the GO term ”ATPase activity” 
(GO:0016887) over time. Such changes can heavily affect the estimation of the background 
distribution in enrichment analyses. To minimise this problem, use an up-to-date version of the 
ontology/annotations and ensure that conclusions drawn hold across recent releases. Data and plot 
obtained from GOTrack (http://www.chibi.ubc.ca/gotrack). 
 
Such large changes in GO annotations can affect GO enrichment analyses, which are sensitive to the 
choice of background distribution (Chap. S. Bauer; 15). For instance, Clarke and al. (16) have shown 
that changes in annotations contribute significantly to changes in over-represented terms in GO 
analysis. To mitigate this problem, researchers should analyse their datasets using the most up-to-
date version of the ontology and annotations, and ensure that the conclusions they draw hold across 
multiple recent releases. At the time of the writing of this chapter, DAVID, a popular GO analysis tool, 
had not been updated since 2009 (http://david.abcc.ncifcrf.gov/forum/viewtopic.php?f=10&t=807). 
Enrichment analyses performed with it may thus identify terms whose distribution has substantially 
changed irrespective of the analysis of interest. The Gene Ontology Consortium now links to the 
PantherDB GO analysis service (http://amigo.geneontology.org/rte) (17). This tool uses the most 
current version of the ontology and the annotations. Regardless of the tool used, researchers should 
disclose the ontology and annotation database releases used in their analyses. 
3. Gene Ontology annotations   
Having discussed common pitfalls associated with the ontology structure, we now turn our attention to 
annotations. Understanding how annotations are done is essential to correctly interpreting the data. In 
particular, the information provided for each GO annotation extends beyond the mere association of a 
term with a protein (reference to GO primer chapter). The full extent of this rich information, aimed to 
more precisely reflect the biology within the GO framework, is often overlooked. 
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3.1 Modification of annotation meaning by qualifiers 
The Gene Ontology uses three qualifiers that modify the meaning of association between a gene-
product and a Gene Ontology term: These are “NOT”, “contributes to”, and  “co-localizes with” (see 
documentation at http://geneontology.org/page/go-qualifiers).  
The “contributes to" qualifier is used to capture the molecular function of complexes when the activity 
is distributed over several subunits. However, in some cases the usage of the qualifier is more 
permissive, and all subunits of a complex are annotated to the same molecular function even if they 
do not make a direct contribution to that activity. For example, the rat G2/mitotic-specific cyclin-B1 
CCNB1 is annotated as contributing to histone kinase activity, based on data in (18), although it has 
only been shown to regulate the kinase activity of CDK1. Finding a cyclin annotated as having protein 
kinase activity may be unintuitive to users who fail to consider the “contributes to” qualifier.  
The “co-localizes with” qualifier is used with two very different meanings:  it first means that a protein 
is transiently or peripherally associated with an organelle or complex, while the second use is for 
cases where the resolution of an assay is not accurate enough to say that the gene product is a bona 
fide component member. Unfortunately, it is currently not possible to know which of the two meanings 
is meant in any given annotation. 
3.2 Negative and contradictory results 
The “NOT” qualifier is the one with the most impact, since it means that there is evidence that a gene 
product does not have a certain function. The “NOT” qualifier is mostly used when a specific function 
may be expected, but has shown to be missing, either based on closer review of the protein’s primary 
sequence (e.g. loss of an active site residue) or because it cannot be experimentally detected using 
standard assays. 
The existence of negative annotations can also lead to apparent contradictions. For instance, protein 
ARR2 in Arabidopsis thaliana is associated with “response to ethylene” (GO:0009723) both positively 
on the basis of a paper by Hass et al. (19) and negatively based on a paper by Mason et al. (20). The 
latter discusses this contradiction as follows: 
“Hass et al. (2004) reported a reduction in the ethylene sensitivity of seedlings containing an arr2 
loss-of-function mutation. By contrast, we observed no significant difference from the wild type in 
the seedling ethylene response when we tested three independent arr2 insertion mutants, 
including the same mutant examined by Hass et al. (2004). This difference in results could arise 
from differences in growth conditions, for, unlike Hass et al. (2004), we used a medium 
containing Murashige and Skoog (MS) salts and inhibitors of ethylene biosynthesis.” 
Thus, in this case, the contradiction in the GO is a reflection of the primary literature. As Mason et al. 
note, this is not necessarily reflective of a mistake, as there can be differences in activity across 
space (tissue, subcellular localisation) and time (due to regulation), with some of these details not fully 
captured in the experiment or in its representation in the GO. 
A NOT annotation may also be assigned to a protein that does not have an activity typical of its 
homologs, for instance the STRADA pseudokinase (UniProtKB:Q7RTN6); STRADA adopts a closed 
conformation typical of active protein kinases and binds substrates, promoting a conformational 
change in the substrate, which is then phosphorylated by a “true” protein kinase, STK11 (21). In this 
case, the “NOT” annotation is created to alert the user to the fact that although the sequence 
suggests that the protein has a certain activity, experimental evidence shows otherwise.  
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In contrast to positive annotations, “NOT” annotations propagate to children in the ontology graph  
and not to parents. To illustrate, a protein associated with a negative annotation to “protein kinase 
activity” is not a tyrosine protein kinase either, a more specific term.  
3.3 Annotation extensions 
As also described in Chapter XX (reference to Lovering & Huntley’s chapter), the Gene Ontology has 
recently introduced a mechanism, the “annotation extensions”, by which contextual information can be 
provided to increase the expressivity of the annotations (22). Until recently, annotations had consisted 
of an association between a gene product and a term from one of the three ontologies comprising the 
GO. With this new knowledge representation model, additional information about the context of a GO 
term such as the target gene or the location of a molecular function may be provided.  
Common uses are to provide data regarding the location of the activity/process in which a protein or 
gene product participates. For example, the role of Mouse opsin-4 (MGI:1353425) in rhodopsin 
mediated signaling pathway is biologically relevant in retinal ganglion cells. Annotation extensions 
also allow capture of dynamic subcellular localization, such as the S. pombe bir1 protein 
(SPCC962.02c), which localizes to the spindle specifically during the mitotic anaphase. The 
annotation extensions can also be used to capture substrates of enzymes, which used to be outside 
the scope of GO. 
The annotation extension data is available in the AmiGO (23) and QuickGO (24) browsers, as well as 
in the annotation files compliant with the GAF2.0 format (http://geneontology.org/page/go-annotation-
file-gaf-format-20). However, because annotation extensions are relatively new, guidelines are still 
being developed, and some uses are inconsistent across different databases. Furthermore, most 
tools have yet to take this information into account. 
In effect, extensions of an annotation create a “virtual” GO class that can be composed of more than 
one “actual” GO class, and can be traced up through multiple parent lineages. Thus, just as with inter-
ontology links, accounting for annotation extensions can result in a substantial inflation in the number 
of annotations, which needs to be appropriately accounted for in enrichment analyses and other 
statistical analyses that require precise specification of GO term background distribution. 
3.4 Biases associated with particular evidence codes 
Annotations are backed by different types of experiments or analyses categorised according to 
evidence codes (x-ref to GO Primer chapter Gaudet et al.). Different types of experiments provide 
varying degrees of precision and confidence with respect to the conclusions that can be derived from 
them. For most experiment types, it is not possible to provide a quantitative measure of confidence. 
Evidence codes are informative but cannot directly be used to exclude low-confidence data.4 
Nonetheless, the different evidence codes are prone to specific biases. 
Direct evidence. Taking these caveats into account, the evidence code inferred from direct assay 
(abbreviated as IDA in the annotation files) provides the most reliable evidence with respect to the 
how directly a protein has been implicated in a given function, as it names implies.   
Mutant phenotype evidence. Mutants are extremely useful to implicate genes products in pathways 
and processes; however exactly how the gene product is implicated in the process/function annotated 
is difficult to assess using phenotypic data because such data are inherently derivative. Therefore, 
associations between gene products and GO terms based on mutant phenotypes (abbreviated as 
                                                       
4 An evidence confidence ontology has been proposed by Bastien at al. (25) but has yet to be 
adopted by the GO project.  
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IMP in the annotation files) may be weak. The same caveat applies to annotations derived from 
mutations in multiple genes, indicated by evidence code “inferred from genetic interaction” (IGI).  
Physical interactions. Evidence based on physical interactions (IPI; mostly protein-protein 
interactions) is comparable in confidence to a direct assay for protein binding annotations or for 
cellular components; however for molecular functions and biological processes, the evidence is of the 
type “guilt by association” and is of low confidence. Inferences based on expression patterns (IEP) 
are typically of low confidence. The presence of a protein in a specific subcellular localization, at a 
specific developmental stage, or associated with a protein or a protein complex can provide a hint to 
uncover a protein’s role in the absence of other evidence, but without more direct evidence that 
information is very weak.  
High-throughput experiments. Schnoes et al. (26) reported that annotations deriving from high-
throughput experiments tend to consist of high-level GO terms, and tend to represent a limited 
number of functions. This artificially decreases the information content of these terms, since they are 
frequently annotated, and artificially decreased information content affects similarity analyses. This 
potentially has a large impact, since a significant fraction of the annotations in the GO database are 
derived from these types of analyses (as much as 25%, according to Schnoes et al., who used the 
operational definition of a high throughput paper as one in which over 100 proteins were annotated). 
The GO does not currently record whether particular experimental annotations may be derived from 
high-throughput methods, but this may change in the future.  
Biases from automatic annotation methods. The GO association file, containing the annotations, 
has information regarding the method used to assign electronic annotations. The annotations can be 
assigned by a large number of different methods. Examples include domain functions, as assigned for 
example by InterPro, by Enzyme Commission numbers being associated with an entry, by BLAST, by 
orthology assignment, etc. Note that this information is not provided as an evidence code, but as a 
“reference code”. The list of methods and their associated reference code is available at 
http://www.geneontology.org/cgi-bin/references.cgi. The large number of electronic annotations can 
also make them have a disproportionate impact on the results. Most analysis tools allow for the 
inclusion or exclusion of electronic annotations, but not at the more fine-grained level of the particular 
method. It is nevertheless possible to use the combination of evidence code plus reference (available 
at: http://www.geneontology.org/cgi-bin/references.cgi) to automatically deepen the evidence type, 
see https://raw.githubusercontent.com/evidenceontology/evidenceontology/master/gaf-eco-
mapping.txt).  
Note that a gene or gene product can have multiple annotations to the same term but with different 
evidence. This can provide corroborating information on particular genes, but may also require 
appropriate normalisation in statistical analyses of term frequency, as the frequency of terms that can 
be determined through multiple types of experiments may be artificially inflated. Furthermore, 
because different experiments can vary in their specificity—thus resulting in annotations at different 
levels of granularity for basically the same function—this redundancy only becomes conspicuous 
when the transitivity of the ontology structure is appropriately taken into account. 
For more discussion on evidence codes, and their use in quality control pipelines, refer to Chap XX 
(Chibucos et al.). 
3.5 Differences among species 
There can be substantial differences in the nature and extent of GO annotations across different 
species. For instance, zebrafish is heavily studied in terms of developmental biology and 
embryogenesis while the rat is the standard model for toxicology. These differences are reflected in 
the frequency of GO terms across species, which can vary considerably across species (27). This has 
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important implications on enrichment analyses and other statistical analyses requiring a background 
distribution of GO annotations. For instance, consider an experiment trying to establish the biological 
processes associated with a particular zebrafish protein by identifying its interaction partners and 
performing an enrichment analysis on them. If we naively use the entire database as background, the 
interaction partners might appear to be enriched in developmental genes simply because this class is 
over-represented in general in zebrafish. Instead, one should use zebrafish gene-related annotations 
only as background (15). 
3.6 Authorship bias 
Other biases are less obvious but can nevertheless be strong and thus have a high potential to 
mislead. Recently, sets of annotations derived from the same scientific article we shown to be on 
average much more similar than annotations derived from different papers (Fig. 3; 27). Unaware of 
this, Nehrt et al. compared the functional similarity of orthologs (genes related through speciation) 
across different species and paralogs (genes related through duplication) within the same species, 
and observed a much higher level of functional conservation among the latter (28). However, this 
difference was almost entirely due to the fact that the GO functional annotations of same-species 
paralogs are ~50 times more likely to be derived from the same paper than orthologs; when 
controlling for the authorship, the difference in functional similarity between same-species paralogs 
and orthologs entirely vanished and even became in favour of orthologs (27). 
Note that the difference is smaller but remains significant if we compare annotations established from 
different papers, but with at least one author in common, with annotations from different articles with 
no author in common. 
 
Fig 3. (a) Average GO annotation similarity (using the measure of Schlicker et al. (29) between 
homologous genes, considering experimental annotations partitioned according to the provenance; 
(b) Average GO annotation similarity between homologous genes, partitioned according to their GO 
annotation evidence tags (Experimental: evidence code EXP and subcategories; Uncurated: evidence 
code IEA; Curated: all other evidence codes). Figure adapted from (27). 
 
3.7 Annotator bias 
Just as systematic differences among investigators can lead to the authorship bias, systematic 
differences in the way GO curators capture this information can lead to annotator bias. These 
annotator biases can in part be attributed to different annotation focus, but also to different 
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interpretation or application of the GO annotation guidelines (http://geneontology.org/page/go-
annotation-policies).  
UniProt provides annotations for all species, which allows us to assess the effect of annotator (or 
database) bias. If we compare UniProt annotations for mouse proteins with those done by the Mouse 
Genome Informatics group (MGI), we see that comparable fractions of proteins are annotated using 
the different experimental evidence codes, with mutant phenotypes being the most widely used (78% 
of experimental annotations in MGI, versus 63% in UniProt, followed by direct assays (20% of 
annotations in MGI and 32% in UniProt).    
However when we look at which GO terms are annotated based on phenotypes (IMP and IGI) by the 
two groups, we notice a large difference in the terms annotated. The top term annotated by MGI 
supported by the IMP evidence code is “in utero embryonic development”, with 1170 annotations to 
1020 proteins. UniProt has only 4 annotations for this term. On the other hand, UniProt has as one of 
its top-annotated classes “regulation of circadian rhythm”, for 49 annotations to 38 proteins; 96 
annotations for 69 proteins if we also include annotations to more specific, descendant terms. MGI on 
the other hand, only has 18 annotations for 19 proteins. This indicates that the annotations provided 
by different groups are biased towards specific aspects, and are not a uniform representation of the 
biology of all gene products in a species.  
3.8 Propagation bias  
Another strong and perhaps surprising bias lies in the very different average GO similarity between 
electronic annotations compared with between experimental annotations. Indeed, if we consider 
homologous genes, their similarity in terms of electronic annotations tend to be much higher than in 
terms of experimental annotations, with curated annotations lying in-between (27; Fig. 3). A likely 
explanation for this phenomenon is that electronic annotations are typically obtained by by inferring 
annotations among  homologous sequences, a process that can only increase the average functional 
similarity of homologs. 
Because of this homology inference bias, one must exercise caution when drawing conclusions from 
sets of genes whose annotations might have different proportions of experimental vs. electronic 
annotations. For instance, this would be the case when comparing annotations from model organisms 
with those from non-model organisms (the latter being likely to consist mostly of electronic 
annotations obtained through propagation). 
More subtly, because function conservation is generally believed to correlate with sequence similarity, 
many computational methods preferentially infer function among phylogenetically close homologs. 
This bias can thus confound analyses attempting to gauge the conservation of gene function across 
different levels of species divergence. 
3.9 Imbalance between positive and negative annotations 
As discussed above, both our knowledge of gene function and its representation in the GO remain 
very incomplete. We have already discussed the pitfalls of ignoring this fact altogether (closed vs. 
open world assumption), or assuming similar term frequencies across species. But the extent of 
missing data varies along other dimensions as well: for example it can depend on how easy it is to 
experimentally establish a particular function and how interesting the potential function might be. The 
problem is particularly acute in the case of negative annotations, because they can be even more 
difficult to establish than their positive counterparts (e.g. a negative result can also be due to 
inadequate experimental conditions, differences in spatio-temporal regulation, etc.) and they are often 
perceived as being less useful, and certainly less publishable. As a result, currently less than 1% of all 
experimental annotations are negative ones in UniProt-GOA (30). This imbalance causes problems 
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with training of machine learning algorithms (31). Rider et al. (32) investigated the reliability of typical 
machine learning evaluation metrics (area under the “receiver operating characteristic” (ROC) curve, 
area under the precision-recall curve) under different levels of missing negative annotations and 
concluded that this bias could strongly affect the ranking obtained from the different metrics. Though 
this particular study adopted a closed world assumption, the effect of a varying proportion of negative 
annotations is likely to be even greater under the open world assumption. 
 
4 Getting help 
This chapter provides a broad overview of some of the pitfalls associated with GO-based analysis. 
Table 1 summarizes the most important pitfalls users encounter using GO.  
Table 1: Main pitfalls or biases discussed in the chapter and their remedies. 
Pitfall or bias Remedy 
Wrongly assume that absence of annotation 
implies absence of function. 
Account for the fact that both ontology and 
annotations are necessary incomplete, for 
instance by assessing the impact of 
incompleteness on one’s analyses and findings. 
Not all directed edges in the ontology structure 
have the same meaning: depending on their 
type, the relationship they represent may or may 
not be transitive. 
The transitivity of each type of relations must be 
taken into account when reasoning over the 
GO. “Is a” and “part of” are transitive, but 
“regulates” and “has part” are not. 
To yield meaningful results, GO enrichment 
analyses require accurate specification of the 
background distribution, which can vary 
substantially across releases, species, etc.  
Specify the actual background distribution used 
in the analysis of interest. Short of this, ensure 
that the enrichment analysis is performed on 
consistent database release and subsets of 
species, terms, etc. To test the robustness of 
results, consider repeating the analysis using 
several releases of GO ontology/annotation 
databases. Avoid tools that are not regularly 
updated. 
Inter-ontology links and annotation extensions 
can result in large variations in the number of 
annotations. Furthermore, annotation 
extensions may not be consistently 
implemented, if at all, across analyses tools or 
workflows. 
Keep track of database releases in analyses. If 
they are relevant, make sure that annotation 
extensions are implemented consistently. 
Qualifiers such as “NOT” or “co-localizes with” 
are important parts of a gene annotation in that 
they fundamentally change the meaning of 
annotations. Because only a small minority of all 
annotations have qualifiers, such errors can 
easily go unnoticed. 
Remember to take into account qualifiers. When 
using tools or software libraries, make sure that 
these take qualifiers into account as well. 
Annotations are supported by different types of 
evidence (categorised by evidence codes). The 
annotations associated with each code vary in 
their scope, specificity, and number. These 
differences can confound some analyses. 
Take evidence code into account. In statistical 
analyses, consider the distribution of 
annotations in terms of evidence codes, and, if 
needed, control for this potential confounder. 
Different species tend to have very different When performing statistical analyses or using 
11 
types of annotations. For instance, model 
species have many more experiment-based 
annotations.  
information-theoretic similarity measures, use 
species-specific frequencies of GO term.   
Experiment-based annotations derived from the 
same research article tend to be more similar 
than annotations derived from different articles. 
Similar trends hold for annotations derived from 
same versus different authors, and same versus 
different annotators. 
Control for authorship bias in analyses that may 
have varying proportion of annotations 
stemming from the same article, lab, or 
annotation team.  
Because annotations are preferentially 
propagated among closely related sequences, 
electronic annotations can confound analyses 
seeking to characterise relationships between 
evolution and function. 
Restrict such analyses to experiment-based 
annotations. Avoid circularity. 
There are many more positive annotations than 
negative annotations. As a result, standard 
accuracy measures used by machine learning 
methods may be misleading (“class imbalance 
problem”). 
Consider false-positive and false-negative rates 
separately. Focus on subset of data for which 
the class imbalance problem is less 
pronounced. 
 
 
Users are advised to make use of a number of excellent resources provided by the GO consortium: 
● The GO website http://geneontology.org 
● The GO FAQ http://geneontology.org/faq-page 
● The GO team are eager to help with with your problems: email go-help@geneontology.org 
● The wider bioinformatics community can be consulted via sites like biostars – see the GO tag 
https://www.biostars.org/t/go/ 
● The GO community can be contacted on Twitter at @news4go  
 
5 Conclusion 
This chapter has surveyed some of the main pitfalls and biases of the Gene Ontology. The number of 
potential issues, summarised in Table 1, may seem daunting. Indeed, as discussed at the start of this 
chapter, there are some inherent risks in working with observational data. However, simple remedies 
are available for many of these (Table 1). By understanding the subtleties of the GO, controlling for 
known confounders, trying to identify unknown ones, and cautiously proceeding forward, users can 
make the most of the formidable resource that is the GO. 
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